Related Experiment Videos
Effect of second-stage 0.25% epidural bupivacaine on the outcome of labor
1Department of Obstetrics and Gynecology, B, Serlin Maternity Hospital, Tel Aviv, Israel.
Gynecologic and Obstetric Investigation
|January 1, 1996
Abstract
Objective:
To evaluate the effect of second-stage epidural bupivacaine on the outcome of labor.
Methods:
Two groups of 35 patients each were randomly allocated to receive continuous epidural bupivacaine throughout labor (group 1) or until an 8-cm dilatation of the cervix (group 2).
Results:
There was no significant difference between the 2 groups in the rates of instrument deliveries and in their Apgar scores.
Conclusions:
The administration of continuous epidural bupivacaine (0.25%) throughout labor and delivery does not seem to affect the outcome of labor.